Indian shares rebound from oil-led losses as IT, Sun Pharma gain - Reuters

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNVWZILVh5d0ZUQmNUR2w4eU5WU2RGVkJ2X0FrdVVEMlhIVTNBWi1mVS1tSUhPdVVlQkRCcDBGZDBfODJFMmNTOTdmX1ZyR2tfOFI1QjQ1S0xFTnRKT0hPNjdjM01fQnRyYWVlemxkcXZVQTV1QXBTdmtnOWd3T3JwRHlWM2VxVXhmYXVMajF3RzIzbzBwLXJOa2dpdTA2SzA?oc=5" target="_blank">Indian shares rebound from oil-led losses as IT, Sun Pharma gain</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

Indian shares rose on Monday, driven by a partial rebound in information technology stocks after recent sharp losses and strong gains in Sun Pharma following its announced $11.75 billion acquisition of U.S.-listed drugmaker Organon.

Indian benchmark indices Sensex and Nifty staged a significant rebound in early trade, buoyed by Sun Pharma's major acquisition of US-based Organon & Co and positive global market trends, ending a three-day period of decline.

Benchmark stock market indices opened higher on Monday, starting the week on a positive note. Pharma and healthcare stocks jumped in early trade on the back of Sun Pharma announcing the biggest acquisition in its history, agreeing to buy US-based Organon & Co. in an all-cash deal valued at $11.75 billion, including debt.